
Silence Therapeutics plc SLN
$ 6.14
-2.07%
Annual report 2023
added 12-13-2025
Silence Therapeutics plc Total Shareholders Equity 2011-2025 | SLN
Annual Total Shareholders Equity Silence Therapeutics plc
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 9.06 M | 20.9 M | 35.1 M | - | - | - | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.1 M | 9.06 M | 21.7 M |
Quarterly Total Shareholders Equity Silence Therapeutics plc
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 8.53 M | - | - | - | 9.06 M | - | - | - | 20.9 M | - | - | - | 35.1 M | - | - | - | 52.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in GBP currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 52.4 M | 8.53 M | 25.2 M |
Total Shareholders Equity of other stocks in the Biotechnology industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
106 M | $ 4.79 | 2.35 % | $ 795 M | ||
|
MorphoSys AG
MOR
|
621 M | - | 2.43 % | $ 254 M | ||
|
Aeglea BioTherapeutics
AGLE
|
518 M | - | - | $ 1.01 B | ||
|
Aclaris Therapeutics
ACRS
|
156 M | $ 3.04 | 4.83 % | $ 235 M | ||
|
Alpine Immune Sciences
ALPN
|
179 M | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
113 M | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
3.36 M | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
60.8 M | - | - | $ 10.1 M | ||
|
BioVie
BIVI
|
19 M | $ 1.27 | -3.05 % | $ 1.88 M | ||
|
Aptorum Group Limited
APM
|
21.1 M | $ 1.17 | 4.46 % | $ 6.38 M | ||
|
Aptevo Therapeutics
APVO
|
4.76 M | $ 0.93 | -8.81 % | $ 257 K | ||
|
Athersys
ATHX
|
16.4 M | - | 3.77 % | $ 22.4 M | ||
|
Avenue Therapeutics
ATXI
|
2.8 M | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
94.7 M | - | 1083.1 % | $ 745 M | ||
|
BioDelivery Sciences International
BDSI
|
188 M | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
3.33 B | - | 0.49 % | $ 251 B | ||
|
Midatech Pharma plc
MTP
|
6.72 M | - | -18.52 % | $ 27.3 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
2.02 M | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
142 M | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
195 M | - | - | $ 546 M | ||
|
Ascendis Pharma A/S
ASND
|
884 M | $ 212.81 | 1.71 % | $ 5 B | ||
|
Calithera Biosciences
CALA
|
8.38 M | - | -10.95 % | $ 876 K | ||
|
Can-Fite BioPharma Ltd.
CANF
|
5.44 M | $ 0.18 | -25.03 % | $ 392 M | ||
|
Catalyst Biosciences
CBIO
|
-15.8 M | $ 12.37 | 2.06 % | $ 814 M | ||
|
Cerevel Therapeutics Holdings
CERE
|
674 M | - | - | $ 7.29 B | ||
|
Alterity Therapeutics Limited
ATHE
|
35.5 M | $ 3.1 | 0.16 % | $ 7.46 B | ||
|
Biophytis SA
BPTS
|
2.27 M | - | -13.47 % | $ 169 M | ||
|
ARCA biopharma
ABIO
|
382 M | - | 1052.0 % | $ 415 M | ||
|
Acasti Pharma
ACST
|
66.6 M | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
39.5 M | - | -15.15 % | $ 60.3 M | ||
|
Celsion Corporation
CLSN
|
4.24 M | - | -6.63 % | $ 13.9 M | ||
|
Albireo Pharma
ALBO
|
176 M | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
1.37 B | $ 95.03 | 0.95 % | $ 27.2 B | ||
|
Corcept Therapeutics Incorporated
CORT
|
680 M | $ 83.59 | 1.95 % | $ 8.63 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
728 M | $ 24.45 | 0.91 % | $ 2.9 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
732 M | $ 26.81 | 1.36 % | $ 1.3 B | ||
|
Anika Therapeutics
ANIK
|
212 M | $ 9.48 | 0.96 % | $ 139 M | ||
|
Cortexyme
CRTX
|
85.1 M | - | -1.05 % | $ 67.1 M | ||
|
CTI BioPharma Corp.
CTIC
|
-17.6 M | - | - | $ 1.2 B | ||
|
Arena Pharmaceuticals
ARNA
|
673 M | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
-16.8 M | - | 2.71 % | $ 14 M | ||
|
Axon Enterprise
AXON
|
2.33 B | $ 591.15 | 0.02 % | $ 44.8 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-1.1 M | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
19 M | $ 2.53 | -0.39 % | $ 15.9 M | ||
|
AstraZeneca PLC
AZN
|
15.6 B | $ 92.45 | 0.34 % | $ 96.9 B | ||
|
Celldex Therapeutics
CLDX
|
747 M | $ 26.83 | 0.94 % | $ 1.73 M | ||
|
Acorda Therapeutics
ACOR
|
-158 M | - | -24.86 % | $ 820 K |